Evidence map›Paper›PMID 38488463›Full record

ArticleClinical and translational medicine2024

Single-cell sequencing reveals alterations in the peripheral blood mononuclear cell landscape and monocyte status during colorectal adenocarcinoma formation.

Jiasheng Xu, Yeting Hu, Jie Zhao, Xiangxing Kong, Sijian Xia, Siqi Dai, Lei Ding, Tongtong Bu, Yue Cao, Manjiao Liu and 6 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical and translational medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Jiasheng XuDepartment of Colorectal Surgery, The Second Hospital of Zhejiang University School of Medicine (Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education, and Key Laboratory of Medical Molecular Biology), Zhejiang University, Hangzhou, China.
Yeting HuDepartment of Colorectal Surgery, The Second Hospital of Zhejiang University School of Medicine (Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education, and Key Laboratory of Medical Molecular Biology), Zhejiang University, Hangzhou, China.ORCID 0000-0001-7483-4380
Jie ZhaoThe State Key Laboratory of Neurology and Oncology Drug Development, Jiangsu Simcere Diagnostics Co., Ltd., Nanjing Simcere Medical Laboratory Science Co., Ltd., Nanjing, China.
Xiangxing KongDepartment of Colorectal Surgery, The Second Hospital of Zhejiang University School of Medicine (Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education, and Key Laboratory of Medical Molecular Biology), Zhejiang University, Hangzhou, China.
Sijian XiaThe State Key Laboratory of Neurology and Oncology Drug Development, Jiangsu Simcere Diagnostics Co., Ltd., Nanjing Simcere Medical Laboratory Science Co., Ltd., Nanjing, China.
Siqi DaiDepartment of Colorectal Surgery, The Second Hospital of Zhejiang University School of Medicine (Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education, and Key Laboratory of Medical Molecular Biology), Zhejiang University, Hangzhou, China.
Lei DingDepartment of Colorectal Surgery, The Second Hospital of Zhejiang University School of Medicine (Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education, and Key Laboratory of Medical Molecular Biology), Zhejiang University, Hangzhou, China.
Tongtong BuDepartment of Colorectal Surgery, The Second Hospital of Zhejiang University School of Medicine (Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education, and Key Laboratory of Medical Molecular Biology), Zhejiang University, Hangzhou, China.
Yue CaoDepartment of Colorectal Surgery, The Second Hospital of Zhejiang University School of Medicine (Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education, and Key Laboratory of Medical Molecular Biology), Zhejiang University, Hangzhou, China.
Manjiao LiuThe State Key Laboratory of Neurology and Oncology Drug Development, Jiangsu Simcere Diagnostics Co., Ltd., Nanjing Simcere Medical Laboratory Science Co., Ltd., Nanjing, China.ORCID 0000-0002-2651-1154
Linlin YanThe State Key Laboratory of Neurology and Oncology Drug Development, Jiangsu Simcere Diagnostics Co., Ltd., Nanjing Simcere Medical Laboratory Science Co., Ltd., Nanjing, China.
Qian XiaoDepartment of Colorectal Surgery, The Second Hospital of Zhejiang University School of Medicine (Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education, and Key Laboratory of Medical Molecular Biology), Zhejiang University, Hangzhou, China.
Hao GuoThe State Key Laboratory of Neurology and Oncology Drug Development, Jiangsu Simcere Diagnostics Co., Ltd., Nanjing Simcere Medical Laboratory Science Co., Ltd., Nanjing, China.ORCID 0000-0002-9289-9775
Ying YuanThe Department of Medical Oncology, the Second Affiliated Hospital of Zhejiang University, Hangzhou, China.
Dong XuDepartment of Colorectal Surgery, The Second Hospital of Zhejiang University School of Medicine (Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education, and Key Laboratory of Medical Molecular Biology), Zhejiang University, Hangzhou, China.
Kefeng DingDepartment of Colorectal Surgery, The Second Hospital of Zhejiang University School of Medicine (Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education, and Key Laboratory of Medical Molecular Biology), Zhejiang University, Hangzhou, China.ORCID 0000-0002-2380-3717

Funding

Fundamental Research Funds for the Central Universities 226-2022-00009Health Planning Committee JBZX-201903Key R&D Program of Zhejiang 2023C03049National Key R&D Program of China 2017YFC0908200National Natural Science Foundation of China 11932017National Natural Science Foundation of China 82072624National Natural Science Foundation of China 82103684project supported by the Scientific Research Fund of Zhejiang University XY2021025
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdenocarcinomaColorectal NeoplasmsHumansLeukocytes, MononuclearMonocytes

Identifiers

PMID38488463
PMCPMC10941536

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.